NCT03894813View on ClinicalTrials.gov

Probiotics as Adjuvant Treatment for Bacterial Vaginosis

PHASE4CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Bacterial Vaginosis
Interventions
DRUG

"Probiotics and Metronidazole"

Oral probiotics (Umeta-Miyue, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14) (qd, 30 days)+Metronidazole Suppositories (qd, 7 days)

DRUG

Metronidazole Vaginal

Metronidazole Suppositories,qd, 7 days

Trial Locations (1)

518036

Peking University Shenzhen Hospital, Shenzhen

All Listed Sponsors
collaborator

BGI, China

OTHER

lead

Peking University Shenzhen Hospital

OTHER

NCT03894813 - Probiotics as Adjuvant Treatment for Bacterial Vaginosis | Biotech Hunter | Biotech Hunter